Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis

Cancer Research

Volumn 65, Issue 16, 2005, Pages 7370-7377

  Koblinski, Jennifer E ^a   Kaplan Singer, Benjamin R ^a   VanOsdol, Sherilyn J ^a   Wu, Michael ^a   Engbring, Jean A ^a   Wang, Songlin ^b   Goldsmith, Corinne M ^a   Piper, John T ^c   Vostal, Jaroslav G ^c   Harms, John F ^d   Welch, Danny R ^e   Kleinman, Hynda K ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d PENN STATE CANCER INSTITUTE   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; MATRIGEL; OSTEONECTIN;

ADENOVIRUS; APOPTOSIS; ARTICLE; BONE METASTASIS; BREAST CANCER; BREAST METASTASIS; CANCER CELL CULTURE; CANCER INVASION; CELL AGGREGATION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; THROMBOCYTOPENIA;

ADENOVIRIDAE; ANIMALS; BLOOD PLATELETS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; FEMALE; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OSTEONECTIN; THROMBOCYTOPENIA;

EID: 23844504520     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0807     Document Type: Article

References (56)

1. Termine JD, Kleinman HK, Whitson SW, et al. Osteonectin, a bone-specific protein linking mineral to collagen. Cell 1981;26:99-105.
2. Framson PE, Sage EH. SPARC and tumor growth: where the seed meets the soil? J Cell Biochem 2004;92:679-90.
3. +2-dependent binding to the extracellular matrix. J Cell Biol 1989;109:341-56.
4. Rosenblatt S, Bassuk JA, Alpers CE, et al. Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: characterization of the binding of vitronectin to osteonectin (BM40, SPARC). Biochem J 1997;324:311-9.
5. Clezardin P, Malaval L, Ehrensperger AS, et al. Complex formation of human thrombospondin with osteonectin. Eur J Biochem 1988;175:275-84.
6. Funk SE, Sage EH. The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc Natl Acad Sci U S A 1991;88:2648-52.
7. Lane TF, Sage EH. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J 1994;8:163-73.
8. Francki A, Bradshaw AD, Bassuk JA, et al. SPARC regulates the expression of collagen type I and transforming growth factor-β1 in mesangial cells. J Biol Chem 1999;274:32145-52.
9. Bos TJ, Cohn SL, Kleinman HK, et al. International Hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactions. Matrix Biol 2004;23:63-9.
10. Ledda MF, Adris S, Bravo AI, et al. Suppression of SPABC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nat Med 1997;3:171-6.
11. Aycock RL, Bradshaw AC, Sage EH, Starcher B. Development of UV-induced squamous cell carcinomas is suppressed in the absence of SPARC. J Invest Dermatol 2004;123:592-9.
12. Schultz C, Lemke N, Ge S, Golembieski WA, Rempel SA. Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo. Cancer Res 2002;62:6270-7.
13. Mok SC, Chan WY, Wong KK, Muto MG, Berkowitz RS. SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells. Oncogene 1996;12:1895-901.
14. Vial E, Castellazzi M. Down-regulation of the extracellular matrix protein SPARC in vSrc- and vJun-transformed chick embryo fibroblasts contributes to tumor formation in vivo. Oncogene 2000;19:1772-82.
15. Colombo MP, Biondi G, Galasso D, et al. Osteonectin transcript and metastatic behavior in v-Ki-ras transformed fibroblasts. Int J Cancer Suppl 1989;4:76-7.
16. Chlenski A, Liu S, Crawford SE, et al. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. Cancer Res 2002;62:7357-63.
17. Brekken RA, Puolakkainen P, Graves DC, et al. Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM. J Clin Invest 2003;111:487-95.
18. Bellahcene A, Castronovo V. Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am J Pathol 1995;146:95-100.
19. Solomayer EF DI, Meyberg GC, Gollan C, Bastert G. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 2000;59:271-8.
20. Jacob K, Webber M, Benayahu D, Kleinman HK. Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone. Cancer Res 1999;59:4453-7.
21. De S, Chen J, Narizhneva NV, et al. Molecular pathway for cancer metastasis to bone. J Biol Chem 2003;278:39044-50.
22. Harms JF, Budgeon LR, Christensen ND, Welch DR. Maintaining GFP tissue fluorescence through bone decalcification and long-term storage. Biotechniques 2002;33:1197-200.
23. Zheng C, Baum BJ, Iadarola MJ, O'Connell BC. Genomic integration and gene expression by a modified adenoviral vector. Nat Biotechnol 2000;18:176-80.
24. Jones N, Shenk T. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 1979;17:683-9.
25. Larsen M, Hoffman MP, Sakai T, et al. Role of PI 3-kinase and PIP3 in submandibular gland branching morphogenesis. Dev Biol 2003;255:178-91.
26. Koblinski JE, Dosescu J, Sameni M, et al. Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B. J Biol Chem 2002;277: 32220-7.
27. Lorch JH, Klessner J, Park JK, et al. Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells. J Biol Chem 2004;279:37191-200.
28. Gu J, Tamura M, Pankov R, et al. She and FAK differentially regulate cell motility and directionality modulated by PTEN. J Cell Biol 1999;146:389-403.
29. Albini A, Iwamoto Y, Kleinman HK, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987;47:3239-45.
30. Sameni M, Moin K, Sloane BF. Imaging proteolysis by living human breast cancer cells. Neoplasia 2000;2:496-504.
31. Arguello F, Baggs RB, Frantz CN. A murine model of experimental metastasis to bone and bone marrow. Cancer Res 1988;48:6876-81.
32. Yoneda T, Sasaki A, Mundy GR. Osteolytic bone metastasis in breast cancer. Breast Cancer Res Treat 1994;32:73-84.
33. Fisher LW, Stubbs JT III, Young MF. Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand Suppl 1995;266:61-5.
34. Zajchowski DA, Bartholdi MF, Gong Y, et al. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res 2001;61:5168-78.
35. Gilles C, Bassuk JA, Pulyaeva H, et al. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Cancer Res 1998;58:5529-36.
36. Porter DA, Krop JE, Nasser S, et al. A SAGE (serial analysis of gene expression) view of breast tumor progression. Cancer Res 2001;61:5697-702.
37. Dhanesuan N, Sharp JA, Blick T, Price JT, Thompson EW. Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition. Breast Cancer Res Treat 2002;75:73-85.
38. Harms JF, Welch DR. MDA-MB-435 human breast carcinoma metastasis to bone. Clin Exp Metastasis 2003;20:327-34.
39. Sellappan S, Grijalva R, Zhou X, et al. Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line. Cancer Res 2004;64:3479-85.
40. Kato Y, Sakai N, Baba M, et al. Stimulation of motility of human renal cell carcinoma by SPARC/Osteonectin/BM-40 associated with type IV collagen. Invasion Metastasis 1998;18:105-14.
41. Rempel SA, Golembieski WA, Fisher JL, Maile M, Nakeff A. SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins. J Neurooncol 2001;53:149-60.
42. Clezardin P, Malaval L, Morel MC, et al. Osteonectin is an α-granule component involved with thrombospondin in platelet aggregation. J Bone Miner Res 1991;6:1059-70.
43. Gasic GJ, Gasic TB, Stewart CC. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A 1968;61:46-52.
44. Gasic GJ, Gasic TB, Galanti N, Johnson T, Murphy S, Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer 1973;11:704-18.
45. Bakewell SJ, Nestor P, Prasad S, et al. Platelet and osteoclast β3 integrins are critical for bone metastasis. Proc Natl Acad Sci U S A 2003;100:14205-10.
46. Watkins G, Douglas-Jones A, Bryce R, Mansel RE, Jiang WG. Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes. Prostaglandins Leukot Essent Fatty Acids 2005;72:267-72.
47. Kim YW, Park YK, Lee J, Ko SW, Yang MH. Expression of osteopontin and osteonectin in breast cancer. J Korean Med Sci 1998;13:652-7.
48. Iacobuzio-Donahue CA, Argani P, Hempen PM, Jones J, Kern SE. The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types. Cancer Res 2002;62:5351-7.
49. Woelfle U, Cloos J, Sauter G, et al. Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res 2003;63:5679-84.
50. Turk N, Kusec R, Jaksic B, Turk Z. Humoral SPARC/osteonectin protein in plasma cell dyscrasias. Ann Hematol 2005;84:304-10.
51. Ledda MF, Adris S, Bover L, et al. The role of SPARC gene in tumorigenic capacity of human melanoma cells. Medicina (B Aires) 1996;56:51-4.
52. Briggs J, Chamboredon S, Castellazzi M, Kerry JA, Bos TJ. Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells. Oncogene 2002;21:7077-91.
53. Lane TF, Iruela-Arispe ML, Johnson RS, Sage EH. SPARC is a source of copper-binding peptides that stimulate angiogenesis. J Cell Biol 1994;125:929-43.
54. Puolakkainen PA, Brekken RA, Muneer S, Sage EH. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis. Mol Cancer Res 2004;2:215-24.
55. Fidler IJ. Metastasis: quantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2′-deoxyuridine. J Natl Cancer Inst 1970;45:773-82.
56. Kelm RJ Jr, Mann KG. The collagen binding specificity of bone and platelet osteonectin is related to differences in glycosylation. J Biol Chem 1991;266:9632-9.